TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma
2011

TMEFF2 and Its Role in Cancer

publication 10 minutes Evidence: moderate

Author Information

Author(s): Lin Kui, Taylor James R. Jr., Wu Thomas D., Gutierrez Johnny, Elliott J. Michael, Vernes Jean-Michel, Koeppen Hartmut, Phillips Heidi S., de Sauvage Frederic J., Meng Y. Gloria

Primary Institution: Genentech, South San Francisco, California, United States of America

Hypothesis

TMEFF2 may function as a tumor suppressor in various cancers by regulating PDGF signaling.

Conclusion

TMEFF2 is downregulated and hypermethylated in glioma and several other cancers, suggesting its important role in cancer development.

Supporting Evidence

  • TMEFF2 interacts with PDGF-AA, which is important for cell growth.
  • TMEFF2 expression is lower in gliomas compared to normal brain tissue.
  • Hypermethylation of TMEFF2 is associated with reduced expression in several cancers.
  • The study provides evidence of TMEFF2's role in regulating PDGF signaling.

Takeaway

TMEFF2 is a protein that helps control cell growth, and when it is turned off in certain cancers, it may help those cancers grow faster.

Methodology

The study involved analyzing TMEFF2's interaction with PDGF-AA and its expression levels in various cancer types through experiments including ELISA and immunoprecipitation.

Potential Biases

Potential bias due to the focus on specific tumor types and the reliance on available data from microarray analyses.

Limitations

The study primarily focuses on specific cancer types and may not generalize to all cancers.

Statistical Information

P-Value

4×10−14

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0018608

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication